Trials / Withdrawn
WithdrawnNCT01547078
Clinical Study of Lyophilized Plasma in Patients With Liver Disease
A Phase 2 Clinical Study of Lyophilized Plasma in Patients With Acquired Coagulopathy Due to Liver Disease
- Status
- Withdrawn
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- HemCon Medical Technologies, Inc · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A multi-center, phase 2, randomized, controlled study of the effect of lyophilized plasma in patients with liver disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Lyophilized Plasma | Licensed plasma that has been lyophilized. |
| BIOLOGICAL | Licensed Plasma | Plasma that has been authorized for transfusion. |
Timeline
- Start date
- 2015-01-01
- Primary completion
- 2016-01-01
- Completion
- 2016-01-01
- First posted
- 2012-03-07
- Last updated
- 2015-03-18
Source: ClinicalTrials.gov record NCT01547078. Inclusion in this directory is not an endorsement.